Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mordechai Muszkat

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Clinical Pharmacokinetics|February 14, 2026
Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly PatientsRachel Goldstein, Khaled Sandouka, Lana Zighan, et al.
Pharmacotherapy|March 28, 2019
Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population-Based Nested Case-Control StudyVictoria Rotshild, Laurent Azoulay, Ilan Feldhamer, et al.
Hypertension (Dallas, Tex. : 1979)|December 6, 2003
Alpha2-adrenergic receptor-induced vascular constriction in blacks and whitesMordechai Muszkat, Gbenga G Sofowora, Alastair J J Wood, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of MacrolidesEinat Gorelik, Reem Masarwa, Amichai Perlman, et al.
Clinical Pharmacokinetics|June 14, 2022
Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin ClearanceChanan Shaul, Simcha Blotnick, Liat Adar, et al.
Pharmacogenetics and Genomics|May 17, 2018
The hemodynamic response to constant dobutamine infusion: the effect of ADRB1 389 polymorphism and sexDotan Yogev, Maamoun Basheer, Amichai Perlman, et al.
Drugs & Aging|June 7, 2011
Risk factors for prescribing and transcribing medication errors among elderly patients during acute hospitalization: a cohort, case-control studyArie Ben-Yehuda, Yitzchak Bitton, Pnina Sharon, et al.
The Israel Medical Association Journal : IMAJ|August 8, 2018
Clinical Spectrum and Mechanism of Acute Kidney Injury in Patients with Diabetes Mellitus on SGLT-2 InhibitorsAmichai Perlman, Samuel N Heyman, Joshua Stokar, et al.
CNS Drugs|March 3, 2023
Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC TreatmentRachel Goldstein, Aviya R Jacobs, Lana Zighan, et al.
Clinical Therapeutics|March 16, 2012
Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort studyIdit Bejarano-Achache, Liran Levy, Liat Mlynarsky, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|February 14, 2026
Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly PatientsRachel Goldstein, Khaled Sandouka, Lana Zighan, et al.
Pharmacotherapy|March 28, 2019
Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population-Based Nested Case-Control StudyVictoria Rotshild, Laurent Azoulay, Ilan Feldhamer, et al.
Hypertension (Dallas, Tex. : 1979)|December 6, 2003
Alpha2-adrenergic receptor-induced vascular constriction in blacks and whitesMordechai Muszkat, Gbenga G Sofowora, Alastair J J Wood, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of MacrolidesEinat Gorelik, Reem Masarwa, Amichai Perlman, et al.
Clinical Pharmacokinetics|June 14, 2022
Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin ClearanceChanan Shaul, Simcha Blotnick, Liat Adar, et al.
Pharmacogenetics and Genomics|May 17, 2018
The hemodynamic response to constant dobutamine infusion: the effect of ADRB1 389 polymorphism and sexDotan Yogev, Maamoun Basheer, Amichai Perlman, et al.
Drugs & Aging|June 7, 2011
Risk factors for prescribing and transcribing medication errors among elderly patients during acute hospitalization: a cohort, case-control studyArie Ben-Yehuda, Yitzchak Bitton, Pnina Sharon, et al.
The Israel Medical Association Journal : IMAJ|August 8, 2018
Clinical Spectrum and Mechanism of Acute Kidney Injury in Patients with Diabetes Mellitus on SGLT-2 InhibitorsAmichai Perlman, Samuel N Heyman, Joshua Stokar, et al.
CNS Drugs|March 3, 2023
Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC TreatmentRachel Goldstein, Aviya R Jacobs, Lana Zighan, et al.
Clinical Therapeutics|March 16, 2012
Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort studyIdit Bejarano-Achache, Liran Levy, Liat Mlynarsky, et al.
Pageof 8